In order to identify novel high value antibacterial targets it is desirable to delineate whether the inactivation of the target enzyme will lead to bacterial death or stasis. This knowledge is particularly important in slow growing organisms, like mycobacteria, where most of the viable anti-tubercular agents are bactericidal. A bactericidal target can be identified through the conditional deletion or inactivation of the target gene at a relatively high cell number and subsequently following the time course of survival for the bacteria. A simple protocol to execute conditional inactivation of a gene is by antisense expression. We have developed a mycobacteria specific IPTG inducible vector system and monitored the effect of antisense inhibition of several known essential genes in mycobacteria by following their survival kinetics. By this method, we could differentiate between genes whose down regulation lead to bacteriostatic or bactericidal effect. Targets for standard anti-tubercular drugs like inhA for isoniazid, rpoB and C for rifampicin, and gyr A/B for flouroquinolones were shown to be bactericidal. In contrast targets like FtsZ behaved in a bacteriostatic manner. Induction of antisense expression in embB and ribosomal RNA genes, viz., rplJ and rpsL showed only a marginal growth inhibition. The specificity of the antisense inhibition was conclusively shown in the case of auxotrophic gene ilvB. The bactericidal activity following antisense expression of ilvB was completely reversed when the growth media was supplemented with the isoleucine, leucine, valine and pantothenate. Additionally, under these conditions the expression of several genes in branched chain amino acid pathway was severely suppressed indicating targeted gene inactivation.
References
[1]
Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685): 537–44.
[2]
Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Reviews Drug Discovery 6: 29–40.
[3]
Gerdes SY (2003) Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J Bacteriol 185(19): 5673–84.
[4]
Hasan S, Daugelat S, Rao SrinivasaPS, Schreiber M (2006) Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosis. PLoS Comput Biol 2(6): e61. Epub 2006 Jun 9.
[5]
Hutchison CA III, Peterson SN, Gill SR, Cline RT, White O, et al. (1999) Global transposon mutagenesis and a minimal Mycoplasma genome. Science 286(5447): 2165–9.
[6]
Sassetti CM, Boydand DH, Rubin EJ (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48(1): 77–84.
[7]
Yinduo Ji, Zhang B, Van Horn SF, Warren P, Woodnutt G, et al. (2001) Identification of critical Staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293: 2266–2269.
[8]
Forsyth RA, Haselbeck RJ, Ohlsen KL, Yamamoto RT, Xu JDH, et al. (2002) A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol Microbiology 43(6): 1387–1400.
[9]
Stratton CW (2003) Dead bugs don't mutate: Susceptibility issues in the emergence of bacterial resistance. Emerging Infectious Diseases 9(1): 10–15.
[10]
Levison ME (2004) Pharmacodynamics of antimicrobial drugs-Review. Infect Dis Clin North Am 18(3): 451–65.
[11]
Siegele DA, Hu JC (1997) Gene expression from plasmids containing the araBAD promoter as subsaturating inducer concentrations represents mixed populations. Proc Natl Acad Sci USA 94: 8168–8172.
[12]
Yagil G, Yagil E (1971) On the relation between effector concentration and the rate of induced enzyme synthesis. Biophys J 11(1): 11–27.
[13]
Unniraman S, Chatterji M, Nagaraja V (2002) DNA gyrase genes in Mycobacterium tuberculosis: a single operon driven by multiple promoters. J Bacteriol 184: 5449–5456.
[14]
Muller-Hill B, Crapo L, Gilbert W (1968) Mutants that make more repressor. Proc Natl Acad Sci USA 59: 1259–1264.
[15]
Bashyam MD, Kaushal D, Dasgupta SK, Tyagi AK (1996) A Study of the mycobacterial transcriptional apparatus: identification of novel features in promoter elements. J Bacteriol 178(16): 4847–4853.
[16]
Jarslaw D, Rutherford SA, Madiraju MV, Atkinson MAL, Rajagopalan M (2003) Conditional expression of Mycobacterium smegmatis ftsZ, an essential cell division gene. Microbiology 149: 1593–1603.
[17]
Blokpoel MCJ, Murphy HN, O'Toole , Wiles RS, Runn ESC, et al. (2005) Tetracycline gene regulation in mycobacteria. Nucleic Acid Res 33(2)e22: 1–7.
[18]
Chauhan A, Murty V V S Madiraju , Fol M, Lofton H, Maloney E, et al. (2006) Mycobacterium tuberculosis cells growing in macrophages are filamentous and deficient in FtsZ rings. J. Bacteriol 188(5): 1856–1865.
[19]
Jain P, Nagaraja V (2002) An orphan gyrB in the Mycobacterium smegmatis genome uncovered by comparative genomics. J Genetics 81(3): 105–110.
[20]
Argyrou A, Vetting MW, Blanchard JS (2007) New insight into the mechanism of action of and resistance to isoniazid: interaction of Mycobacterium tuberculosis enoyl-ACP reductase with INH-NADP. J Am Chem Soc 129(31): 9582–9583.
[21]
Sullivan TJ, Truglio JJ, Boyne ME, Novichenok P, Zhang X, et al. (2006) High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains of Mycobacterium tuberculosis. ACS Chem Biol 1(1): 43–53.
[22]
Shi R, Zhang J, Otomo K, Zhang G, Suguwara I (2007) Lack of Correlation between embB Mutation and Ethambutol MIC in Mycobacterium tuberculosis Clinical Isolates from China. Antimicrob Agents and Chemother 51(12): 4515–4517.
[23]
Amin AG, Goude R, Shi L, Zhang J, Chatterjee D, Parish T (2008) EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis. Microbiology 154: 240–248.
[24]
Kohanski MA, Dwyer DJ, Wierzbowsk J, Cottarel G, James JC (2008) Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135: 679–690.
[25]
Patek M (2007) Branched chain amino acids. Microbiol. Monogr (5). VF Wendisch. Amino acid biosynthesis. DOI 10.1007/ 7171_2006_70/ Published online 1st Feb 2007. Springer Verlag Berlin Heidelberg 2007.
[26]
Parish T, Turner J, Stoker NG (2001) amiA is a negative regulator of acetamidase expression in Mycobacterium smegmatis. BMC Microbiology I: 19–23.
[27]
Sabine E, Guo XV, Hickey C, Ryou MM, Monteleone M, et al. (2005) Controlling gene expression in mycobacteria with anhydrotetracycline and tet repressor. Nucleic Acid Res 33(2) e22: 1–11.
[28]
Chattopadhyay S, Das B, Dasgupta C (1996) Reactivation of Denatured Proteins by 23S Ribosomal RNA: Role of Domain V. Proc. Natl Acad of Sci US 93(16): 8284–8287.
[29]
Deutscher MP (2003) Degradation of Stable RNA in Bacteria. J Biol Chem 278(46): 45041 –45044.
[30]
Dwyer DJ, Kohanski MA, Hayete B, Collins JJ (2007) Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Systems Biology 3: 91–105.
[31]
Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797–810.
[32]
Froehlich BJ, Scott JR (1991) A single promoter-cloning vector for use in Escherichia coli. Gene 108(1): 99–101.
[33]
Stolt P, Stoker NG (1996) Protein-DNA interactions in the ori region of the Mycobacterium fortuitum plasmid pAL5000. J Bacteriol 178: 6693–6700.
